Skip to main content
. 2011 Jul;338(1):12–21. doi: 10.1124/jpet.111.179390

Fig. 3.

Fig. 3.

Increased GSK-3β inactivation in FXR-KO mice. A, Western blot analysis of total and Ser9-phosphorylated GSK-3β, Ser45-Thr41-phosphorylated β-catenin, and Dvl performed using liver homogenates from WT and FXR-KO mice. B, densitometric analysis of blots in A. Data are expressed as mean ± S.D. Statistical significance: *, P < 0.05; **, P < 0.01.